Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34 + selected graft.

MLA

Lin, Richard J., et al. “Favorable Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for CMML with Myeloablative Conditioning, Anti-Thymocyte Globulin, and CD34 + Selected Graft.” Bone Marrow Transplantation, vol. 55, no. 8, Aug. 2020, pp. 1632–34. EBSCOhost, https://doi.org/10.1038/s41409-019-0723-x.

APA

Lin, R. J., Sanchez, M., Abbi, K., Devlin, S. M., Jakubowski, A. A., Papadopoulos, E. B., Barker, J. N., Tamari, R., Young, J. W., Gyurkocza, B., Ponce, D. M., Dahi, P. B., Maloy, M. A., Giralt, S. A., Perales, M.-A., & Castro-Malaspina, H. (2020). Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34 + selected graft. Bone Marrow Transplantation, 55(8), 1632–1634. https://doi.org/10.1038/s41409-019-0723-x

Chicago

Lin, Richard J, Matias Sanchez, Kamal Abbi, Sean M Devlin, Ann A Jakubowski, Esperanza B Papadopoulos, Juliet N Barker, et al. 2020. “Favorable Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for CMML with Myeloablative Conditioning, Anti-Thymocyte Globulin, and CD34 + Selected Graft.” Bone Marrow Transplantation 55 (8): 1632–34. doi:10.1038/s41409-019-0723-x.